Mobile App tracks Parkinson’s

Capturing a patient’s experience outside the doctor’s office has been an ongoing struggle when it comes to treating Parkinson’s disease. But now a new smartphone app can now detect the severity of symptoms in patients with Parkinson’s disease remotely, according…

Read More
Parkinson Food

Food and Parkinson’s

Parkinson’s Disease (PD) is not something you hear a lot of in the news, especially compared to other neurodegenerative diseases like Alzheimer’s, but it affects a significant percentage of the population: one to two percent of Americans over the age…

Read More

New Parkinson Drug Approved

Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the U.S. Food and Drug Administration (FDA) has approved GOCOVRI (amantadine) extended release capsules (previously ADS-5102) for treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic…

Read More

Old drug may have potential disease-modifying effects.

The type 2 diabetes drug exenatide (Bydureon, Byetta, AstraZeneca) has potential disease-modifying effects in Parkinson's disease, results of a randomized, double-blind, placebo-controlled trial suggest. Study results show the glucagon-like peptide-1 (GLP-1) receptor agonist improved off-medication motor scores in patients with…

Read More
Parkinson Scam

BEWARE of scam treatments and promises

Nearly one-third of the advertisements for “memory-boosting” supplements reviewed by a government watchdog may be illegally claiming to cure or prevent diseases like Parkinson’s or Alzheimer’s, according to a recent report. The report suggests that government regulation is failing to…

Read More